Optimal Lymph Node Yield for Survival Prediction in Rectal Cancer Patients After Neoadjuvant Therapy.
Yu-Min LinChia-Lin ChouYu-Hsuan KuoHung-Chang WuChia-Jen TsaiChung-Han HoYi-Chen ChenChing-Chieh YangCheng-Wei LinPublished in: Cancer management and research (2021)
Neoadjuvant therapy significantly reduces the LN yield in subsequent surgery. A lower yield (LN ≥ 10) may be adequate for nodal evaluation in rectal cancer patients after neoadjuvant therapy.
Keyphrases
- rectal cancer
- lymph node
- locally advanced
- neoadjuvant chemotherapy
- end stage renal disease
- minimally invasive
- ejection fraction
- newly diagnosed
- chronic kidney disease
- sentinel lymph node
- squamous cell carcinoma
- radiation therapy
- coronary artery disease
- acute coronary syndrome
- early stage
- bone marrow
- mesenchymal stem cells